factor

(redirected from GM-CSF)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
Related to GM-CSF: interleukin, Cytokines, Sargramostim

Factor

An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

factor

n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

factor

(Commission merchant), noun agent, broker, commercial agent, delegate, deputy, envoy, interagent, manager, medium, middleman, one who sells for factorage, proctor, procurator, representative
Associated concepts: consignee, factors' lien

factor

(Ingredient), noun additive, agent, aid, aspect, cause, component, constituent, constitutive element, content, contributing force, determinant, element, elementary unit, feature, integral part, part, portion, segment, unit
See also: aspect, broker, cause, characteristic, component, constituent, dealer, deputy, determinant, element, feature, ingredient, member, part, plenipotentiary, portion, procurator, reason, represent, substitute

factor

1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
References in periodicals archive ?
The researchers found that the mice with GM-CSF had a better chance of survival than the other mice.
On comparing the patients to the control group by serum levels of GM-CSF, we noted considerably lower GM-CSF levels in the sera of vitiligo patients; the mean [+ or -] SD was 33.
Effects of recombinant chicken GM-CSF and IL-4 collectively and individually on cell segregation were recorded by observing cell morphology, clustering, none clustering and maturation of cell.
After a 24 h incubation period, GM-CSF induced no increase in CCR3 expression on eosinophils and was not modulated by co-incubation with different concentrations (0.
6] Nonstandard abbreviations: MIA, multiplex immunoassay; SGBS, Simpson-Golabi Behmel syndrome; RBP-4, retinol binding protein 4; PAI-1, plasminogen activator inhibitor 1; SAA-1, serum amyloid A1; TIMP-1, tissue inhibitor of metalloproteinase 1; HPE, high-performance ELISA; LLOD, lower limit of detection; LLOQ, lower limit of quantitation; GM-CSF, granulocyte-macrophage colony-stimulating factor; HGF, hepatocyte growth factor; IL, interleukin; MCP-1, monocyte chemoattractant protein 1; MIF, macrophage migration inhibitory factor; NGF, nerve growth factor; MIP-1[alpha], macrophage inflammatory protein 1[alpha]; TNF-[alpha], tumor necrosis factor [alpha].
GM-CSF mouthwashes have been shown to cause marked alleviation of existing oral mucositis in several studies without detectable systemic accumulation of GM-CSF upon systemic neutrophil count.
Several studies have demonstrated treatment efficacy in the use of subcutaneous (49,50) or aerosolized (51) GM-CSF for patients with idiopathic PAP.
The researchers confirmed that GM-CSF mouthwash conferred no benefit to oral mucositis despite promising results in preclinical and phase I trials and further recommended that other agents are similarly scrutinised using an RCT design.
The association between infection and GM-CSF concentrations persisted even after the investigators controlled for center, tobacco use, and bacterial vaginosis, said Dr.
Methylcellulose semi-solid media (Stem Cell Technologies, Inc, Vancouver, BC) containing the following growth factors: stem cell factor (50 ng/mL), GM-CSF (10 ng/mL), Interleukin-3 (10 ng/mL), and Erythropoietin (3 U/mL).
When given to chronically HIV-infected patients during an STI, GM-CSF blunted viral rebound and substantially prevented decreases in CD4 T cells in the absence of antiretroviral treatment.
5 when a research group led by assistant professor Kenzaburo Tani removed the man's right kidney and then introduced immunity-enhancing GM-CSF genes into cancer cells taken from the diseased kidney.